Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by skyhigh123on Mar 09, 2018 3:16pm

212 Views

Post# 27693673

RE:RE:RE:RE:Prometic still on track for BLA

FDA BLA Approval for thi Company was April 6 ( a week before PLI s date of April 14 /2018) I feel that we are going to be very very happy very soon !

TH Theratechnologies inc. PDUFA

WhenTuesday, Apr 3, 2018

Description2018-04-03 In a notice received today by TaiMed from the FDA, the Prescription Drug User Fee Act ("PDUFA") target action date has been extended to April 3, 2018. https://www.globenewswire.com/news-release/2017/11/14/1230335/0/en/Theratechnologies-Announces-Decision-by-the-FDA-to-Extend-the-Ibalizumab-Review-Period-to-April-3-2018.html

Bullboard Posts

Gold, growth and sustainability in focus for Mandalay Resources